DN
DNAPrint Genomics, Inc.
DNAG · OTC
$0.00 +0.00% (+$0.00)
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
-
N/A ROIC N/A
Asset turnover N/A
ROE N/A
Debt
-
N/A Debt/Equity N/A
Debt/Assets N/A
Current ratio N/A
Stability
31 /100
Unstable Beta 1.53x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na DNAG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jatin Patel
Employees
24
Headquarters
Sarasota